Fenwick & West LLP advised Databricks on the deal. Databricks, a leader in unified data analytics, announced its $1 billion Series G financing. The round was...
Databricks’ $1 Billion Series G Financing
Ortho Clinical Diagnostics’ $1,292 Million Initial Public Offering
Latham & Watkins LLP represented Ortho in the offering, while Cahill represented the underwriters. Ortho Clinical Diagnostics Holdings plc (Ortho) has announced the pricing of its...
Science Strategic Acquisition Corp. Alpha’s $310.5 Million IPO
Morrison & Foerster LLP advised Science Strategic Acquisition Corp. Alpha on the deal. Science Strategic Acquisition Corp. Alpha (the “Company”) announced that it closed its initial...
Fertitta Entertainment’s $6.6 Billion Merger with Fast Acquisition Corp.
Latham & Watkins LLP represented Fertitta Entertainment, Inc. in the SPAC transaction, while Goodwin Procter LLP and Skadden, Arps, Slate, Meagher & Flom LLP represented Jefferies...
GGV Capital’s $2.5 Billion Funds Raising
Cooley LLP advised GGV Capital on the deal. GGV Capital raised $2.52 billion across four funds, which will focus on tech startups and growth deals in...
Lincoln Road and Trivest Partners’ Investment in Landmark Paving
Holland & Knight LLP advised Lincoln Road Global Management, LLC and Trivest, LP on the deal. Lincoln Road Global Management, LLC, a private equity firm focused...
Orange’s Creation of Orange Concessions
Latham & Watkins, Weil, Gotshal & Manges and Dentons advised Orange on the deal, while Willkie advised the consortium led by Banque des Territoires, CNP Assurances...
Spins’s Growth Investment
Kirkland & Ellis advised Warburg Pincus, while Reed Smith LLP advised SPINS on the deal. Paul, Weiss advised General Atlantic on the deal. SPINS, a leading...
Esme Learning Solutions’ $7.5M Series A Financing
Wilmer Cutler Pickering Hale and Dorr LLP advised Esme Learning Solutions on the deal. Esme Learning Solutions, a leading digital learning platform, announced the close of...
Design Therapeutics’ $125 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Design Therapeutics and Logos Capital on the deal. Design Therapeutics, a biotechnology company developing a platform of gene-targeted chimera small...
Corsair Gaming’s $301.9 Million Secondary Follow-on Offering
Jones Day acted as legal counsel to funds managed by EagleTree Capital, LP. Corsair Gaming, Inc. (NASDAQ:CRSR) (“Corsair”), a leading global provider and innovator of high-performance...
Celsion Corporation’s $35 Million Shares Offering
Baker McKenzie advised Celsion Corporation on the deal. Celsion Corporation, an oncology drug development company, in its registered direct offering of 25,925,925 shares of common stock...